PDLI Financial Facts
General and administrative expenses: 10.4MTotal revenues: 53.64M
See Full Income Statement
Accounts payable: 7.13M
Cash and cash equivalents: 106.59M
See Full Balance Sheet
PDL BioPharma, Inc. (PDLI) Earnings
|
Expand Research on PDLI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -577.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/14  |
 |
Q214 | $0.52 | $0.46 | +$0.06 | $162.8M | $134.07M | N/A |  | | Details |
| 3/3/14 |
|
Q413 | $0.39 | $0.43 | -$0.04 | $110.1M | $115.22M | N/A | | | Details |
| 5/12/14 |
|
Q114 | $0.44 | $0.45 | -$0.01 | $139.7M | $130.93M | N/A | | | Details |
| 11/6/13 |
|
Q313 | $0.36 | $0.37 | -$0.01 | $97.3M | $97.09M | N/A | | | Details |
| 8/8/13 |
|
Q213 | $0.62 | $0.54 | +$0.08 | $143.6M | $138.2M | N/A | | | Details |
| 11/10/14 |
|
Q314 | $0.61 | $0.56 | +$0.05 | $164.6M | $165.1M | N/A | | | Details |
| 5/9/13 |
|
Q113 | $0.36 | $0.35 | +$0.01 | $91.8M | $91.69M | N/A | | | Details |
| 11/5/12 |
|
Q312 | $0.32 | $0.30 | +$0.02 | $85.2M | $85.03M | N/A | | | Details |
